Tirzepatide is a synthetic peptide with dual GIP and GLP-1 receptor agonist activity. This pharmaceutical-grade compound is supplied as a lyophilized white powder with 99% purity for research purposes only.
As a GLP-1 receptor agonist similar to semaglutide, tirzepatide may share some potential semaglutide side effects including gastrointestinal disturbances. Researchers should carefully evaluate these semaglutide side effects when conducting studies.
The compound has shown promise in clinical research for:
- Glycemic control improvement
- Weight management applications
- Metabolic syndrome research
Storage requirements:
- Maintain refrigerated (2-8°C)
- Protect from light and moisture
- Avoid repeated freeze-thaw cycles
Understanding potential semaglutide side effects is crucial for researchers working with related compounds like tirzepatide. This includes monitoring for gastrointestinal effects and other metabolic changes during studies.